VIGL Vigil Neuro: Forvard narx/daromad multiplikatori
Vigil Neuroscience biomateriallar ta'minotini optimallashtirmoqda va miyani himoya qiluvchi terapiyalarni yaratish uchun neyroimmunologik ittifoqlarni rivojlantirmoqda. Oldingi P/S ko'rsatkichi ushbu strategiyaning samaradorligini vizuallashtiradi, bunda joriy baholash darajasini ko'rsatadi. Yuqori R&D xarajatlari va mikroglial dori vositalari uchun patent himoyasi raqobatchilar uchun sezilarli to'siq yaratib, aktivning uzoq muddatli barqarorligini ta'minlaydi.
Vigil Neuroscience kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Vigil Neuroscience|VIGL - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Vigil Neuroscience, Inc.|VIGL - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Vigil Neuroscience, Inc.|VIGL - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzlari Vigil Neuroscience|Tezkor likvidlik vigilneuro.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
VIGL - Kompaniya foydasi|Prognoz qilingan kelajakdagi foyda Vigil Neuroscience|VIGL - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori Vigil Neuroscience, Inc.|VIGL - O‘sish sur’atiga tuzatilgan narx-foyda|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Vigil Neuroscience, Inc.|VIGL - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Bir aksiya uchun sof foyda (EPS TTM) Vigil Neuroscience|VIGL - So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi vigilneuro.com|VIGL - Joriy yilda bir aksiya uchun sof foydaning o'zgarishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Vigil Neuroscience
- kompaniyaning sotuvlari va tushumi statistikasi:
Kompaniyaning barcha koʻrsatkichlari tahlili:Vigil Neuro VIGL
Ushbu ko'rsatkich Vigil Neuroscience (VIGL) kompaniyasining joriy bozor qiymatini prognoz qilingan savdo hajmlari bilan solishtiradi va bu kelajakdagi pul oqimlari uchun to'langan premiumni baholash imkonini beradi. Forward sotuvlar nisbatini tahlil qilish orqali investor dori moddalari ta'minot zanjirlarining barqarorligi operatsion xatarlarni qanday kamaytirishini ko'rishi mumkin, bu esa bevosita kompaniyaning fundamental qiymatiga va grafikdagi investitsiya jozibadorligiga ta'sir qiladi.
Raqobatdosh kompaniyalar tahlili
Forvard P/S multiplikatori BIIB (Biogen)|Neurocrine (NBIX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|RGC: Forvard narx/daromad multiplikatori|AXSM - Forvard P/S multiplikatori|ACADIA Pharmaceuticals (ACAD) - Narxning prognoz qilingan daromadga nisbati|xenon-pharma.com - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Therapeutics, Inc.|Bozor kapitallashuvining kelajakdagi daromadga nisbati Supernus Pharmaceuticals, Inc. SUPN|Narxning prognoz qilingan daromadga nisbati Catalyst Pharmaceuticals Inc (CPRX)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Denali Corp|Forvard P/S multiplikatori HRMY (Harmony Biosciences)|BHVN - Forvard narx/daromad multiplikatori|Amylyx Pharmaceuticals, Inc. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Trevi Therapeutics Inc TRVI|PRAX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Anavex Life Sciences Corp (AVXL)|Narxning prognoz qilingan daromadga nisbati CeriBell, Inc.|Kapitalizatsiyaning prognoz qilingan daromadga nisbati PRTA (Prothena Corporation)|Forvard P/S multiplikatori ALEC|Forvard narx/daromad multiplikatori Annexon Biosciences ANNX|Forvard P/S multiplikatori OMER (Omeros)|Neurogene Therapeutics (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ACIU: Forvard narx/daromad multiplikatori|VYGR: Narxning prognoz qilingan daromadga nisbati|NMRA: Forvard P/S multiplikatori|SCLX - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|TVGN (Tevogen Bio Holdings, Inc.) - Forvard P/S multiplikatori|ACOG - Prognoz narxning daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Cognition Therapeutics (CGTX)|Narxning prognoz qilingan daromadga nisbati IKT (inhibikase.com)|Narxning prognoz qilingan daromadga nisbati Cassava Sciences SAVA|ASRT: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Coya - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Vistagen Therapeutics|OVID (ovidrx.com) - Forvard narx/daromad multiplikatori|acumenpharm.com (ABOS) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati CervoMed|ATHE: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Clene Inc. (CLNN)|PEPG - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Jupiter Neurosciences Inc - Forvard narx/daromad multiplikatori|relmada.com - Narxning prognoz qilingan daromadga nisbati|Annovis Bio - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Grace Therapeutics, Inc. GRCE|AIFF: Forvard P/S multiplikatori|Prognoz narxning daromadga nisbati Klotho Neurosciences KLTO|NRSN (NeuroSense Therapeutics Ltd) - Forvard P/S multiplikatori|revivapharma.com (RVPH) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati MetaVia Inc (MTVA)|Narxning prognoz qilingan daromadga nisbati NRXS (NeurAxis Inc.)|Helius Medical Technologies - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx PASG|NEUP - Narxning prognoz qilingan daromadga nisbati|NERV (minervaneurosciences.com) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ATHA: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Addex Therapeutics Ltd. (ADXN)|Forvard narx/daromad multiplikatori ALZN|Forvard P/S multiplikatori Cyclerion|Narxning prognoz qilingan daromadga nisbati Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Cortigent CRGT|Avenue Therapeutics Inc. (ATXI) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|BCLI - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cara Therapeutics Inc CARA|CHRO: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Eliem Therapeutics Inc.|ITCI (Intra-Cellular Therapies Inc.) - Forvard P/S multiplikatori|Longboard Pharmaceuticals Inc (LBPH) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori MRNS|NKGN - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati NeuroBo Pharmaceuticals NRBO|SAGE: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Synaptogenix - Forvard P/S multiplikatori|Trevena Inc. (TRVN) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Cerevel Corp (CERE)
